Table 1.
Summary of subject demographics
| Characteristic | |
| Female, n (%) | 37 (61.7) |
| Age at enrollment (yrs), median (IQR) | 27 (29–50) |
| Disease duration (yrs), median (IQR) | 9.5 (2.5–20.5) |
| Location of strictures | |
| Ileal, n (%) | 49 (78.3) |
| Colonic, n (%) | 2 (3.3) |
| Ileocolonic, n (%) | 1 (1.7) |
| Unknowna, n (%) | 8 (13.3) |
| Previous surgery, n (%) | 23 (38.3) |
| Concomitant medication | |
| 5-ASA, n (%) | 3 (5) |
| 6-MP, n (%) | 3 (5) |
| Steroids, n (%) | 16 (26.7) |
| Antibiotics, n (%) | 8 (13.3) |
| Immunosuppressants, n (%) | 7 (11.7) |
| Anti-TNF antibodies, n (%) | 7 (11.7) |
| Anti-integrins, n (%) | 2 (3.3) |
| Other biologics, n (%) | 2 (3.3) |
| Other, n (%) | 7 (11.7) |
5-ASA, 5-aminosalicylic acid; 6-MP, mercaptopurine; IQR, interquartile range; TNF, tumor necrosis factor.
a
Unknown because of patient discontinuation before determination of stricture location.